Nucyro Vascular, LLC
Country not established
- Devices
- 1
What Nucyro Vascular, LLC makes
Nucyro Vascular, LLC manufactures the PolarCath Peripheral Dilatation System, a device designed for percutaneous transluminal angioplasty in peripheral arteries to treat stenosis or occlusions.
The PolarCath Peripheral Dilatation System is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
PolarCath Peripheral Dilatation System Ref K152665
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nucyro Vascular, LLC have in the registry?
The registry currently lists 1 device for Nucyro Vascular, LLC. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nucyro Vascular, LLC's devices?
Among its 1 most recently registered device, Nucyro Vascular, LLC has devices listed in FDA 510(k) (1 device).
What risk classes do Nucyro Vascular, LLC's devices fall under?
Among its 1 most recently registered device, the classes recorded for Nucyro Vascular, LLC's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Nucyro Vascular, LLC in the registry?
The most recently registered devices listed for Nucyro Vascular, LLC include PolarCath Peripheral Dilatation System.